| Bioactivity | 3’-O-t-Bulyldimethylsilylthymidine is a purine nucleoside analog. Purine nucleoside analogs have broad antitumor activity targeting indolent lymphoid malignancies. Anticancer mechanisms in this process rely on inhibition of DNA synthesis, induction of apoptosis, etc[1]. | ||||||||||||
| Name | 3’-O-t-Bulyldimethylsilylthymidine | ||||||||||||
| CAS | 40733-27-5 | ||||||||||||
| Formula | C16H28N2O5Si | ||||||||||||
| Molar Mass | 356.49 | ||||||||||||
| Appearance | Solid | ||||||||||||
| Transport | Room temperature in continental US; may vary elsewhere. | ||||||||||||
| Storage |
|
||||||||||||
| Reference | [1]. Robak T, Robak P. Purine nucleoside analogs in the treatment of rarer chronic lymphoid leukemias. Curr Pharm Des. 2012;18(23):3373-88. |
3’-O-t-Bulyldimethylsilylthymidine
CAS: 40733-27-5 F: C16H28N2O5Si W: 356.49
3’-O-t-Bulyldimethylsilylthymidine is a purine nucleoside analog. Purine nucleoside analogs have broad antitumor activi
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.